AKM Azad

Abanti Bhattacharjya, Md Manowarul Islam, Md Ashraf Uddin et al.

With the advent of Information technology, the Bioinformatics research field is becoming increasingly attractive to researchers and academicians. The recent development of various Bioinformatics toolkits has facilitated the rapid processing and analysis of vast quantities of biological data for human perception. Most studies focus on locating two connected diseases and making some observations to construct diverse gene regulatory interaction networks, a forerunner to general drug design for curing illness. For instance, Hypopharyngeal cancer is a disease that is associated with EGFR-mutated lung adenocarcinoma. In this study, we select EGFR-mutated lung adenocarcinoma and Hypopharyngeal cancer by finding the Lung metastases in hypopharyngeal cancer. To conduct this study, we collect Mircorarray datasets from GEO (Gene Expression Omnibus), an online database controlled by NCBI. Differentially expressed genes, common genes, and hub genes between the selected two diseases are detected for the succeeding move. Our research findings have suggested common therapeutic molecules for the selected diseases based on 10 hub genes with the highest interactions according to the degree topology method and the maximum clique centrality (MCC). Our suggested therapeutic molecules will be fruitful for patients with those two diseases simultaneously.

Md Shofiqul Islam, Khondokar Fida Hasan, Hasibul Hossain Shajeeb et al.

This study presents a comprehensive review of the potential of multimodal deep learning (DL) in medical diagnosis, using COVID-19 as a case example. Motivated by the success of artificial intelligence applications during the COVID-19 pandemic, this research aims to uncover the capabilities of DL in disease screening, prediction, and classification, and to derive insights that enhance the resilience, sustainability, and inclusiveness of science, technology, and innovation systems. Adopting a systematic approach, we investigate the fundamental methodologies, data sources, preprocessing steps, and challenges encountered in various studies and implementations. We explore the architecture of deep learning models, emphasising their data-specific structures and underlying algorithms. Subsequently, we compare different deep learning strategies utilised in COVID-19 analysis, evaluating them based on methodology, data, performance, and prerequisites for future research. By examining diverse data types and diagnostic modalities, this research contributes to scientific understanding and knowledge of the multimodal application of DL and its effectiveness in diagnosis. We have implemented and analysed 11 deep learning models using COVID-19 image, text, and speech (ie, cough) data. Our analysis revealed that the MobileNet model achieved the highest accuracy of 99.97% for COVID-19 image data and 93.73% for speech data (i.e., cough). However, the BiGRU model demonstrated superior performance in COVID-19 text classification with an accuracy of 99.89%. The broader implications of this research suggest potential benefits for other domains and disciplines that could leverage deep learning techniques for image, text, and speech analysis.

Sakifa Aktar, Md. Martuza Ahamad, Md. Rashed-Al-Mahfuz et al.

Introduction: For COVID-19 patients accurate prediction of disease severity and mortality risk would greatly improve care delivery and resource allocation. There are many patient-related factors, such as pre-existing comorbidities that affect disease severity. Since rapid automated profiling of peripheral blood samples is widely available, we investigated how such data from the peripheral blood of COVID-19 patients might be used to predict clinical outcomes. Methods: We thus investigated such clinical datasets from COVID-19 patients with known outcomes by combining statistical comparison and correlation methods with machine learning algorithms; the latter included decision tree, random forest, variants of gradient boosting machine, support vector machine, K-nearest neighbour and deep learning methods. Results: Our work revealed several clinical parameters measurable in blood samples, which discriminated between healthy people and COVID-19 positive patients and showed predictive value for later severity of COVID-19 symptoms. We thus developed a number of analytic methods that showed accuracy and precision for disease severity and mortality outcome predictions that were above 90%. Conclusions: In sum, we developed methodologies to analyse patient routine clinical data which enables more accurate prediction of COVID-19 patient outcomes. This type of approaches could, by employing standard hospital laboratory analyses of patient blood, be utilised to identify, COVID-19 patients at high risk of mortality and so enable their treatment to be optimised.